Approval of olaparib offers men first gene-targeted medicine for prostate cancer
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the US…
Browsing: PROfound trial
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
ESMO 2019: Targeted therapy slows progression of advanced prostate cancer
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…